Leadartis is currently funded by Growth Factor Biocapital, Bionexum Ventures and other angel investors as well as non-dilutive grants.

Other funding

Leadartis R&D activities, facilities and equipment have been co-financed by the Ministry of Economy and Competitiveness-MINECO (Torres Quevedo Programme calls 2009, 2011 and 2013), by the 2013-2016 State Plan of Scientific and Technical Research and Innovation (Collaboration Challenge Programme-RETOS) and by the 7th European Framework Programme (FP7) in addition to own funds. Additionally, we have been supported by the Genoma España Foundation and by the Carlos III Health Institute.

Latest News

Leadartis successfully accomplishes the TERET project

Leadartis is proud to announce the successful conclusion of the TERET (New Treatments for...

LeadArtis participates in the third Immunostimulatory Agonist Antibodies for Cancer Therapy (IACT) meeting

The third IACT review meeting took place on October 25-26, 2016 in Frankfurt, Germany. LeadArtis...

Leadartis to present at BioSpain 2016 in Bilbao

Leadartis will participate in BioSpain 2016 to be held...